AR053541A1 - Combinacion de xolair con agente inmunosupresor - Google Patents
Combinacion de xolair con agente inmunosupresorInfo
- Publication number
- AR053541A1 AR053541A1 ARP060100378A ARP060100378A AR053541A1 AR 053541 A1 AR053541 A1 AR 053541A1 AR P060100378 A ARP060100378 A AR P060100378A AR P060100378 A ARP060100378 A AR P060100378A AR 053541 A1 AR053541 A1 AR 053541A1
- Authority
- AR
- Argentina
- Prior art keywords
- xolair
- combination
- pharmaceutically acceptable
- immunosuppressing agent
- case
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Composicion farmacéutica que comprende un anticuerpo anti-IgE y cuando menos un agente inmunosupresor adicional, en donde los ingredientes activos están presentes en cada caso en forma libre o en la forma de una sal farmacéuticamente aceptable, y opcionalmente cuando menos un vehículo farmacéuticamente aceptable; para su uso simultáneo, separado, o en secuencia. Estuche terapéutico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0502358.5A GB0502358D0 (en) | 2005-02-04 | 2005-02-04 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AR053541A1 true AR053541A1 (es) | 2007-05-09 |
Family
ID=34355808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060100378A AR053541A1 (es) | 2005-02-04 | 2006-02-02 | Combinacion de xolair con agente inmunosupresor |
Country Status (20)
Country | Link |
---|---|
US (1) | US20080206237A1 (es) |
EP (1) | EP1846031A1 (es) |
JP (1) | JP2008528650A (es) |
KR (1) | KR20070100344A (es) |
CN (1) | CN101111265A (es) |
AR (1) | AR053541A1 (es) |
AU (1) | AU2006210098A1 (es) |
BR (1) | BRPI0607349A2 (es) |
CA (1) | CA2595976A1 (es) |
GB (1) | GB0502358D0 (es) |
GT (1) | GT200600023A (es) |
IL (1) | IL184713A0 (es) |
MA (1) | MA29273B1 (es) |
MX (1) | MX2007009436A (es) |
NO (1) | NO20074497L (es) |
PE (1) | PE20061203A1 (es) |
RU (1) | RU2007132980A (es) |
TN (1) | TNSN07304A1 (es) |
TW (1) | TW200640487A (es) |
WO (1) | WO2006082052A1 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0607740A2 (pt) * | 2005-02-08 | 2009-09-29 | Novartis Ag | indução de anticorpos antilinfócitos |
EP4238993A3 (en) | 2008-04-11 | 2023-11-29 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
LT3190128T (lt) * | 2008-09-17 | 2019-01-10 | Xencor, Inc. | Kompozicijos ir būdai, skirti ige sukeltų sutrikimų gydymui |
AR079645A1 (es) * | 2009-12-18 | 2012-02-08 | Sanofi Aventis | Anticuerpos antagonistas y sus fragmentos fab contra la proteina de las membranas plaquetarias humanas glicoproteina vi (gpvi) y sus usos |
SG190727A1 (en) | 2010-11-30 | 2013-07-31 | Chugai Pharmaceutical Co Ltd | Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly |
KR102147548B1 (ko) | 2011-02-25 | 2020-08-24 | 추가이 세이야쿠 가부시키가이샤 | FcγRIIb 특이적 Fc 항체 |
JO3177B1 (ar) * | 2011-04-01 | 2018-03-08 | Novartis Ag | تركيبات تتالف من 2-أمينو-2- [ 2- ( 4- أكتيل فينيل ) إثيل ] بروبان - 3, 1- ديول |
JP6322411B2 (ja) | 2011-09-30 | 2018-05-09 | 中外製薬株式会社 | 複数の生理活性を有する抗原の消失を促進する抗原結合分子 |
SG11201607165YA (en) | 2014-12-19 | 2016-09-29 | Chugai Pharmaceutical Co Ltd | Anti-c5 antibodies and methods of use |
TWI808330B (zh) | 2014-12-19 | 2023-07-11 | 日商中外製藥股份有限公司 | 抗肌抑素之抗體、含變異Fc區域之多胜肽及使用方法 |
TW202248212A (zh) | 2015-02-05 | 2022-12-16 | 日商中外製藥股份有限公司 | 包含離子濃度依賴之抗原結合域的抗體、Fc區變體、IL-8結合抗體與其用途 |
TW202339800A (zh) | 2015-02-27 | 2023-10-16 | 日商中外製藥股份有限公司 | Il-6受體抗體用於製備醫藥組成物的用途 |
WO2017106859A1 (en) | 2015-12-18 | 2017-06-22 | University Of Notre Dame Du Lac | Covalent heterobivalent antibody inhibitors and ligands |
EP3394098A4 (en) | 2015-12-25 | 2019-11-13 | Chugai Seiyaku Kabushiki Kaisha | ANTI-MYOSTATIN ANTIBODIES AND METHODS OF USE |
GB201610198D0 (en) | 2016-06-10 | 2016-07-27 | Ucb Biopharma Sprl | Anti-ige antibodies |
EP3494991A4 (en) | 2016-08-05 | 2020-07-29 | Chugai Seiyaku Kabushiki Kaisha | COMPOSITION FOR PREVENTING OR TREATING DISEASES RELATING TO IL-8 |
JP7191833B2 (ja) | 2017-01-30 | 2022-12-19 | 中外製薬株式会社 | 抗スクレロスチン抗体およびその使用 |
JOP20190271A1 (ar) | 2017-05-24 | 2019-11-21 | Novartis Ag | بروتينات مطعّمة بسيتوكين- الجسم المضاد وطرق الاستخدام للاضطرابات المتعلقة بالمناعة |
DE102017215154A1 (de) | 2017-08-30 | 2019-02-28 | Markus Bläss | Zusammensetzung zur topischen Behandlung von nicht-Mikroorganismus-verursachten entzündlichen Haut- und Schleimhauterkrankungen |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5994511A (en) * | 1997-07-02 | 1999-11-30 | Genentech, Inc. | Anti-IgE antibodies and methods of improving polypeptides |
US6172213B1 (en) * | 1997-07-02 | 2001-01-09 | Genentech, Inc. | Anti-IgE antibodies and method of improving polypeptides |
GB0200429D0 (en) * | 2002-01-09 | 2002-02-27 | Novartis Ag | Organic compounds |
-
2005
- 2005-02-04 GB GBGB0502358.5A patent/GB0502358D0/en not_active Ceased
-
2006
- 2006-01-18 GT GT200600023A patent/GT200600023A/es unknown
- 2006-02-02 JP JP2007553536A patent/JP2008528650A/ja active Pending
- 2006-02-02 AR ARP060100378A patent/AR053541A1/es not_active Application Discontinuation
- 2006-02-02 RU RU2007132980/13A patent/RU2007132980A/ru not_active Application Discontinuation
- 2006-02-02 WO PCT/EP2006/000911 patent/WO2006082052A1/en active Application Filing
- 2006-02-02 US US11/814,871 patent/US20080206237A1/en not_active Abandoned
- 2006-02-02 PE PE2006000134A patent/PE20061203A1/es not_active Application Discontinuation
- 2006-02-02 AU AU2006210098A patent/AU2006210098A1/en not_active Abandoned
- 2006-02-02 MX MX2007009436A patent/MX2007009436A/es not_active Application Discontinuation
- 2006-02-02 EP EP06706581A patent/EP1846031A1/en not_active Withdrawn
- 2006-02-02 KR KR1020077017947A patent/KR20070100344A/ko not_active Application Discontinuation
- 2006-02-02 CN CNA2006800039151A patent/CN101111265A/zh active Pending
- 2006-02-02 CA CA002595976A patent/CA2595976A1/en not_active Abandoned
- 2006-02-02 BR BRPI0607349-2A patent/BRPI0607349A2/pt not_active Application Discontinuation
- 2006-02-03 TW TW095103825A patent/TW200640487A/zh unknown
-
2007
- 2007-07-19 IL IL184713A patent/IL184713A0/en unknown
- 2007-08-03 TN TNP2007000304A patent/TNSN07304A1/en unknown
- 2007-08-28 MA MA30171A patent/MA29273B1/fr unknown
- 2007-09-04 NO NO20074497A patent/NO20074497L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20061203A1 (es) | 2006-12-19 |
RU2007132980A (ru) | 2009-03-10 |
BRPI0607349A2 (pt) | 2009-09-01 |
AU2006210098A1 (en) | 2006-08-10 |
IL184713A0 (en) | 2007-12-03 |
CA2595976A1 (en) | 2006-08-10 |
CN101111265A (zh) | 2008-01-23 |
MA29273B1 (fr) | 2008-02-01 |
MX2007009436A (es) | 2007-08-17 |
JP2008528650A (ja) | 2008-07-31 |
US20080206237A1 (en) | 2008-08-28 |
TW200640487A (en) | 2006-12-01 |
NO20074497L (no) | 2007-10-26 |
KR20070100344A (ko) | 2007-10-10 |
TNSN07304A1 (en) | 2008-12-31 |
GB0502358D0 (en) | 2005-03-16 |
EP1846031A1 (en) | 2007-10-24 |
GT200600023A (es) | 2006-08-16 |
WO2006082052A1 (en) | 2006-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR053541A1 (es) | Combinacion de xolair con agente inmunosupresor | |
BR0112311A (pt) | Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso | |
AR019507A1 (es) | Uso de los inhibidores de cyp2d6 en terapias de combinacion | |
AR061348A1 (es) | Preparados estables de laquinimod | |
CO6331425A2 (es) | Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida | |
AR033808A1 (es) | Una composicion topica de anestesia local y los parches y los envases que la contienen | |
AR033342A1 (es) | Una composicion otica topica o intranasal para tratar el dolor otico y el uso topico de agonistas de opioides kapa para tratar el dolor otico | |
ECSP077999A (es) | Formulaciones de una sal de bupropion de liberación modificada | |
MX2009004203A (es) | Combinaciones de paracetamol/ibuprofeno y metodo para su uso. | |
AR018109A1 (es) | FORMULACIoN GALÉNICA ADMINISTRABLE POR VíA ORAL QUE PERMITE UNA ABSORCIoN MEJORADA DE PRINCIPIOS ACTIVOS, USO DE UN AGENTE MAJORADOR DE ABSORCIoN PARA PREPARAR UNA FORMA DE DOSIFICACIoN ADMINISTRABLE POR VíA ORAL Y PROCEDIMIENTO PARA PREPARAR DICHA FORMULACIoN GALÉNICA | |
EA200700042A1 (ru) | РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА | |
PA8625001A1 (es) | Composiciones de pelicula | |
ES2178479T3 (es) | Concentrado de principio activo con formoterol, apto para el almacenamiento. | |
AR035977A1 (es) | Inmunoconjugados de anticuerpos cd44 citotoxicos. | |
CL2009001899A1 (es) | Composicion farmaceutica que comprende: i) un antagonista del receptor de at1 o una sal, ii) un sensibilizante a la insulina o una sal y iii) un vehiculo farmaceuticamente aceptable; uso para la prevencion, demora de progreso o tratamiento de hipertension, diabetes, entre otras (div. sol. 2034-01). | |
UY27727A1 (es) | Nueva composicion farmacéutica- | |
BR0306732A (pt) | Tratamentos em combinação para doença alérgica compreendendo a administração de um anticorpo anti-ige e composto antialérgico | |
AR056517A1 (es) | Composiciones y metodos farmaceuticos utilizando temozolomida y un inhibidor de la proteina quinasa | |
AR052048A1 (es) | Composiciones farmaceuticas para el tratamiento de la celulitis | |
CO5550418A2 (es) | Formulaciones antihistaminicas para formas de dosificacion de capsula blanda | |
UY28762A1 (es) | Nuevos compuestos | |
EA200702386A1 (ru) | Твердая фармацевтическая композиция для продолжительного высвобождения 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения | |
CL2007001763A1 (es) | Composicion farmaceutica en forma de una tableta multicapas que comprende una primera region que comprende una tetraciclina y un vehiculo, y una segunda region que comprende un tampon y un segundo vehiculo; formulacion acuosa; y uso para tratar o prevenir la mucositis oral. | |
DE602004014964D1 (de) | Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel | |
AR046955A1 (es) | Preparacion efervescente de una sustancia basica farmaceuticamente activa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |